Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05856981 | Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors | recruiting | Phase 1 | 130 | Sairopa B.V.INDUSTRY | 3 | Dec 17, 2025 | clinicaltrials |
| NCT07283029 | Activity and Cancer Survivorship Exercise Pilot | active not recruiting | N/A | 10 | University of IowaOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT03422198 |
| Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer(SAVE) |
| recruiting |
| Phase 3 |
| 188 |
| University of UtahOTHER |
| 1 |
| Dec 12, 2025 |
| clinicaltrials |
| NCT07278986 | CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer(CYTALUX ISS) | recruiting | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06795009 | Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer | recruiting | Phase 1 | 36 | Washington University School of MedicineOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06943521 | A Study of MT-4561 in Patients With Various Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 27 | Tanabe Pharma America, Inc.INDUSTRY | 2 | Dec 11, 2025 | clinicaltrials |
| NCT07273383 | Self-sampling for HPV Screening(HPVselftest) | active not recruiting | N/A | 1,000 | Université de SherbrookeOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT05077215 | Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer | not yet recruiting | Phase 3 | 450 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
| NCT05106127 | Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem | not yet recruiting | Phase 2 | 28 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07269535 | A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma | not yet recruiting | — | 500 | Tongji HospitalOTHER | 0 | Dec 8, 2025 | clinicaltrials |
| NCT06349148 | The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients | recruiting | N/A | 50 | SHUANG ZHENG JIA, PhDOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07267780 | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. | not yet recruiting | — | 130 | National Cancer Institute, NaplesOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT05201547 | Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line(DOMENICA) | active not recruiting | Phase 3 | 260 | ARCAGY/ GINECO GROUPOTHER | 10 | Dec 4, 2025 | clinicaltrials |
| NCT07070518 | Study of GV20-0251 in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 350 | GV20 TherapeuticsINDUSTRY | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07256977 | Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer(SOLUTION2) | not yet recruiting | N/A | 494 | Seoul National University HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07258186 | Generation of Endometrial Carcinoma Organoids(organoids endo) | recruiting | — | 20 | Regina Elena Cancer InstituteOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07232654 | Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC | recruiting | Phase 2 | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT03983954 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | active not recruiting | Phase 1 | 120 | NeoTX Therapeutics Ltd.INDUSTRY | 2 | Nov 28, 2025 | clinicaltrials |
| NCT07248878 | Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy(Cervical organ) | recruiting | — | 24 | Regina Elena Cancer InstituteOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07249021 | This is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre BT MR as Per IBS-GECESTRO-ABS Recommendations for Target contouring-as an Alternative to MRIGABT for Cervical Cancer From Implementation Perspectives Under EMBRACE-III:TRIPLET IMPACT Study.(IMPACT) | not yet recruiting | — | 1,200 | Homi Bhabha Cancer Hospital & Research CentreOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT06572774 | Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya(C3Link) | active not recruiting | N/A | 5,400 | ImplenomicsOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07081984 | Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors | recruiting | Phase 1 | 12 | TherornaINDUSTRY | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07244965 | Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 42 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04537156 | Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) | active not recruiting | Phase 3 | 9,327 | Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05238883 | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 72 | HiFiBiO TherapeuticsINDUSTRY | 2 | Nov 21, 2025 | clinicaltrials |
| NCT04982237 | A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer | active not recruiting | Phase 3 | 445 | AkesoINDUSTRY | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07230444 | Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization(AI-EMBO) | not yet recruiting | — | 250 | Emanuele BarabinoOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07235787 | Efficacy of Ultrasound Guided Microwave Ablation in the Treatment of Uterine Fibroids.(MWAUF) | not yet recruiting | N/A | 20 | Jihad Hussien Mohamed MahmoudOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06935305 | OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer(SENT-OSNA) | recruiting | N/A | 1,922 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05812027 | A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors | active not recruiting | — | 1,150 | TScan Therapeutics, Inc.INDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05924217 | Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France(GYDECAT) | active not recruiting | — | 300 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05973487 | A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors | active not recruiting | Phase 1 | 840 | TScan Therapeutics, Inc.INDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT07230626 | SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | not yet recruiting | Phase 3 | 412 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 0 | Nov 17, 2025 | clinicaltrials |
| NCT05997017 | Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer | recruiting | Phase 2 | 29 | Aadi Bioscience, Inc.INDUSTRY | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06677112 | MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer | recruiting | N/A | 625 | Rachel MillerOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07084168 | Multimedia Aid for Genetic Testing in Gynecologic Oncology | recruiting | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT07226037 | Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)(DOSE-CC) | not yet recruiting | N/A | 80,000 | Boston Medical CenterOTHER | 0 | Nov 10, 2025 | clinicaltrials |
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | recruiting | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT07044505 | Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery | recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | recruiting | Phase 1 / Phase 2 | 200 | Volastra Therapeutics, Inc.INDUSTRY | 1 | Nov 4, 2025 | clinicaltrials |
| NCT06481592 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. | recruiting | Phase 2 | 60 | Iovance Biotherapeutics, Inc.INDUSTRY | 1 | Oct 30, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT04574635 | Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer | active not recruiting | — | 18 | Mayo ClinicOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib(DURAFAK) | recruiting | Phase 2 | 55 | University of OklahomaOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT04586959 | Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer(MAN-U) | recruiting | N/A | 278 | Anthony Costales, MDOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT04106414 | Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment | active not recruiting | Phase 2 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT06577220 | Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement | active not recruiting | N/A | 111 | Baylor College of MedicineOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT07213427 | Outcomes of Image-guided High-dose-rate Uterovaginal Brachytherapy With Single Implantation(UNICURE-HD) | not yet recruiting | — | 363 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Oct 8, 2025 | clinicaltrials |
| NCT04250766 | Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)(BIOPSAR) | active not recruiting | N/A | 19 | Institut BergoniéOTHER | 1 | Oct 2, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Dec 17, 2025source: clinicaltrials